AZD-3965
98%
- Product Code: 109621
CAS:
1397255-09-2
Molecular Weight: | 439.32 g./mol | Molecular Formula: | C₂₂H₂₀BrFN₄ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
AZD-3965 is primarily investigated for its potential in cancer therapy, particularly in targeting cancer cells that rely heavily on glycolysis for energy production. It functions as a monocarboxylate transporter 1 (MCT1) inhibitor, which disrupts the lactate transport essential for the survival and proliferation of these cancer cells. This makes it a promising candidate for treating tumors with high glycolytic activity, such as certain types of lymphoma and solid tumors. Research is ongoing to evaluate its efficacy in combination with other therapies, aiming to enhance its anticancer effects and overcome resistance mechanisms. Additionally, its role in modulating the tumor microenvironment is being explored to improve immune responses against cancer.
Product Specification:
Test | Specification |
---|---|
Appearance | White To Off-White Solid |
Purity (%) | 97.5-100 |
Infrared Spectrum | Conforms To Structure |
NMR | Conforms To Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.010 | 10-20 days | ฿42,561.00 |
+
-
|
AZD-3965
AZD-3965 is primarily investigated for its potential in cancer therapy, particularly in targeting cancer cells that rely heavily on glycolysis for energy production. It functions as a monocarboxylate transporter 1 (MCT1) inhibitor, which disrupts the lactate transport essential for the survival and proliferation of these cancer cells. This makes it a promising candidate for treating tumors with high glycolytic activity, such as certain types of lymphoma and solid tumors. Research is ongoing to evaluate its efficacy in combination with other therapies, aiming to enhance its anticancer effects and overcome resistance mechanisms. Additionally, its role in modulating the tumor microenvironment is being explored to improve immune responses against cancer.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :